Enzyme slowly binding inhibitor

The structure of the complex of urease with urea in the active site is unknown, because the enzyme-substrate intermediate is very short-lived and has not been trapped. Nevertheless, a number of inhibitors of urease that bridge between the nickel atoms are known. Acetohydroxamate is the most studied and binds slowly but with high affinity (K = 4 vaM [25]). Phosphoroamide is also a slowly binding inhibitor. 2-Thioethanol causes the appearance of sulfur-to-nickel... 

If protease inhibitors should be identified and characterized, the assay should be tested for signal stability and endpoint linearity in the next step. The progress curves recorded for substrate concentrations near or below the KM value should be linear for up to 2 h. Such signal stability is a prerequisite to run the assay with a pre-incubation time of 1 h for enzyme and inhibitor. This long pre-incubation is recommended to ensure also that the IC50 values for slowly binding inhibitors are correctly determined. An additional hour for the incubation of enzyme, inhibitor and substrate after this pre-incubation is recommended. 

Some inhibitors bind to, or dissociate from, their target enzymes slowly, thus leading to a time dependence for the onset of inhibition. 

Some inhibitors interact very slowly with the enzyme protein, and onset of inhibition thus exhibits time-dependence. These inhibitors are generally referred to as slow-binding inhibitors, and as slow tight-binding inhihitors if the potency of inhibition is extremely high. Analysis of these inhibitory mechanisms is complex because binding and dissociation rate constants may be determined in addition to values. Indeed, a complete analysis may require extensive use of specialized computer software, and the complexities of such analyses preclude their discussion in this chapter. However, the reader is directed to several publications from Morrison s laboratory if a slow-binding mechanism is suspected for an inhibitor of interest (Morrison, 1982 Morrison and Stone, 1985 Sculley and Morrison, 1986 Morrison and Walsh, 1988). 

The IMI herbicides also exhibit complex interactions with AHAS. When enzyme activity was measured over an extended period in the presence of various concentrations of imazapyr, inhibition increased with time, thereby suggesting that the equilibrium between the herbicide and AHAS was reached slowly, a characteristic of tight-binding inhibitors [51]. In contrast to SUs, substrate-inhibitor studies suggested that inhibition by imazapyr is uncompetitive with respect to pyruvate, which implies that the synthetic molecule binds to AHAS only after formation of the ternary enzyme-pyruvate-ThDP complex [52]. However, noncompetitive binding has also been reported for the IMIs, which underscores the complexity of the kinetics of AHAS inhibition [49]. 

If the inhibition is found to be rapidly reversible, we must next determine if the approach to equilibrium for the enzyme-inhibitor complex is also rapid. As described in Chapter 4, some inhibitors bind slowly to their target enzymes, on a time scale that is long in comparision to the time scale of the reaction velocity measurement. The effect of such slow binding inhibition is to convert the linear progress curve seen in the absence of inhibitor to a curvilinear function (Figure 5.10). When nonlinear progress curves are observed in the presence of inhibitor, the analysis of... 

The hallmark of slow binding inhibition is that the degree of inhibition at a fixed concentration of compound will vary over time, as equilibrium is slowly established between the free and enzyme-bound forms of the compound. Often the establishment of enzyme-inhibitor equilibrium is manifested over the time course of the enzyme activity assay, and this leads to a curvature of the reaction progress curve over a time scale where the uninhibited reaction progress curve is linear. We saw... 

Noncompetitive inhibitors, conversely, do not affect substrate binding, but produce a ternary complex (enzyme-substrate-inhibitor) which either decomposes slowly, or fails to decompose (i.e., is inactive). Consequently, the primary effect of a noncompetitive inhibitor is to reduce the apparent value of Vmax. 

Inhibition of enzyme activity by a chemical species that binds slowly and is tight-binding as well has a low dissociation constant). Such inhibitors require special kinetic analysis . The most common method of obtaining the inhibition parameters is by nonlinear regression analysis of the progress curves. 

A straightforward approach is to hunt for short polypeptides that meet the specificity requirement of an enzyme but which, because of peculiarities of the sequence, are acted upon very slowly. Such a peptide may contain unusual or chemically modified amino acids. For example, the peptide Thr-Pro-nVal-NMeLeu-Tyr-Thr (nVal=norvaline NMeLeu = N-methylleucine) is a very slow elastase substrate whose binding can be studied by X-ray diffraction and NMR spectroscopy.6 Thiol proteases are inhibited by succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide, which includes a sequence common to a number of naturally occurring peptide inhibitors called cystatins.f They are found in various animal tissues where they inhibit cysteine proteases. 

The serine proteases act by forming and hydrolyzing an ester on a serine residue. This was initially established using the nerve gas diisopropyl fluorophosphate, which inactivates serine proteases as well as acetylcholinesterase. It is a very potent inhibitor (it essentially binds in a 1 1 stoichiometry and thus can be used to titrate the active sites) and is extremely toxic in even low amounts. Careful acid or enzymatic hydrolysis (see Section 9.3.6.) of the inactivated enzyme yielded O-phosphoserine, and the serine was identified as residue 195 in the sequence. Chy-motrypsin acts on the compound cinnamoylimidazole, producing an acyl intermediate called cinnamoyl-enzyme which hydrolyzes slowly. This fact was exploited in an active-site titration (see Section 9.2.5.). Cinnamoyl-CT features a spectrum similar to that of the model compound O-cinnamoylserine, on denaturation of the enzyme in urea the spectrum was identical to that of O-acetylserine. Serine proteases act on both esters and amides. 

In the presence of substrate, product, or an inhibitor, stabilization of the biocatalyst is often observed because the enzyme molecule unfolds more slowly or in harsher conditions in the presence of a bound molecule, particularly if binding is tight (low Khl, KP, or Kt). 

Irreversible inhibitors may be classified for convenience as active site directed inhibitors and suicide or irreversible mechanism based inhibitors (IMBIs). They bind to the enzyme by either strong non-covalent or strong covalent bonds. Inhibitors bound by strong non-covalent bonds will slowly dissociate, releasing the enzyme to carry out its normal function. However, whatever the type of binding, the enzyme will resume its normal function once the organism has synthesized a sufficient number of additional enzyme molecules to overcome the effect of the inhibitor. 

Studies in recent years have revealed a number of remarkable drug interactions with irreversible or mechanism-based inhibitors of CYP3A, many of which can be attributed to inhibition of sequential intestinal and hepatic first-pass metabolism. Mechanism-based inhibition involves the metabolism of an inhibitor to a reactive metabolite, which either forms a slowly reversible metabolic-intermediate (MI) complex with the heme moiety or inactivates the enzyme irreversibly via covalent binding to the enzyme catalyzing the last step in the bioactivation sequence. As a result, mechanism-based inhibition is both... 

---